Novel immunotherapeutics against LGR5 to target multiple cancer types

Hung Chang Chen, Nico Mueller, Katherine Stott, Chrysa Kapeni, Eilidh Rivers, Carolin M. Sauer, Flavio Beke, Stephen J. Walsh, Nicola Ashman, Louise O’Brien, Amir Rafati Fard, Arman Godsinia, Changtai Li, Fadwa Joud, Olivier Giger, Inti Zlobec, Ioana Olan, Sarah J. Aitken, Matthew Hoare, Richard MairEva Serrao, James D. Brenton, Alicia Garcia-Gimenez, Simon E. Richardson, Brian Huntly, David R. Spring, Mikkel Ole Skjoedt, Karsten Skjødt, Marc de la Roche*, Maike de la Roche*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Novel immunotherapeutics against LGR5 to target multiple cancer types'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases